Global and United States Exome Sequencing Market Report & Forecast 2022-2028

Market Analysis and Insights: Global and United States Exome Sequencing Market
This report focuses on global and United States Exome Sequencing market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Exome Sequencing market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Agilent HaloPlex accounting for % of the Exome Sequencing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Mendelian disease and rare syndrome gene discovery was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Exome Sequencing market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Exome Sequencing Scope and Market Size
Exome Sequencing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Exome Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Exome Sequencing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Segment by Application
Mendelian disease and rare syndrome gene discovery
The research of complex diseases
Mouse exome sequencing
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Illumina TruSeq Exome
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene